These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 21057748)
1. Severe pneumonia caused by combined infection with Pneumocystis jiroveci, parainfluenza virus type 3, cytomegalovirus, and Aspergillus fumigatus in a patient with Stevens-Johnson syndrome/toxic epidermal necrolysis. Lee T; Bae YJ; Park SK; Park HJ; Kim SH; Cho YS; Moon HB; Lee SO; Kim TB Acta Derm Venereol; 2010 Nov; 90(6):625-9. PubMed ID: 21057748 [TBL] [Abstract][Full Text] [Related]
2. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China. Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979 [TBL] [Abstract][Full Text] [Related]
3. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes. Tan SK; Tay YK Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108 [TBL] [Abstract][Full Text] [Related]
4. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475 [TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome. Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Yang Y; Xu J; Li F; Zhu X Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study. Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514 [TBL] [Abstract][Full Text] [Related]
9. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases. Chen J; Wang B; Zeng Y; Xu H Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352 [TBL] [Abstract][Full Text] [Related]
10. Stevens-Johnson Syndrome and toxic epidermal necrolysis: a multi-aspect comparative 7-year study from the People's Republic of China. Sun J; Liu J; Gong QL; Ding GZ; Ma LW; Zhang LC; Lu Y Drug Des Devel Ther; 2014; 8():2539-47. PubMed ID: 25548516 [TBL] [Abstract][Full Text] [Related]
11. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867 [TBL] [Abstract][Full Text] [Related]
12. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829 [TBL] [Abstract][Full Text] [Related]
14. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital. Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525 [TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Schneider JA; Cohen PR Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852 [TBL] [Abstract][Full Text] [Related]
16. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results. Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions. Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341 [TBL] [Abstract][Full Text] [Related]
18. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis. Ririe MR; Blaylock RC; Morris SE; Jung JY J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282 [TBL] [Abstract][Full Text] [Related]
19. [Drug-induced toxic epidermal necrolysis with secondary aspergillus fumigatus infection: a case report]. Zhang S; Liu XY; Zhang JZ; Cai L; Zhou C Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 51(5):977-980. PubMed ID: 31624410 [TBL] [Abstract][Full Text] [Related]
20. [Mechanisms of Severe Cutaneous Adverse Reactions and a New Treatment Strategy]. Saito Y; Nakamura R Yakugaku Zasshi; 2019; 139(12):1557-1562. PubMed ID: 31787645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]